Send feedback

MAPRE2 p.Leu101=

c.303G>A · VCV3339046

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0156%, eas)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 10GERP 2, phastCons 1
Overall
CADD13.11PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0156% East Asian · 7/44,886 alleles
Filtering AF 0.00726% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00514%
Overall 0.00136% 22/1,613,796 alleles · ultra-rare exomes 21/1,461,592 · genomes 1/152,204 · joint denominator
Ancestry group Frequency 1 in
East Asiangrpmax 0.0156% 6,412
South Asian 0.00329% 30,357
Remaining individualsnot grpmax-eligible 0.0016% 62,474
Finnishnot grpmax-eligible 0.00156% 64,022
European (non-Finnish) 0.000848% 117,987

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAPRE2
Protein
p.Leu101=
Coding
c.303G>A
MANE Select
NM_014268
Type
single nucleotide variant
Location
chr18:35097498 (GRCh38)
Gene constraint
LOEUF 0.494 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 75.12
Residue 101
the calponin-homology (ch) domain
Full MAPRE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mapre2-p-leu101 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown